Myc g-quadruplex stabilizing small molecules and their use
AssigneesThe United States of America as represented by the Secretary, Department of Health and Human Service, Yale University
InventorsJohn Schneekloth, JR., John Simmons, Kenneth Felsenstein, Beverly Mock, Lindsey Saunders, Peter Gareiss, David Calabrese, Elena Leon
Life of this patent
Estimating the term…
Abstract
Methods for treating a tumor, such as a benign or malignant tumor, are disclosed herein. The methods include administering a therapeutically effective amount of a small molecule that selectively binds to and stabilizes G-quadruplex DNA in the promoter of the c-MYC gene to the subject. The methods are also of use to decrease the size and/or number of metastases. Compounds for use in the disclosed methods are also provided.
Claims30
A method of decreasing c-Myc expression in a cell, comprising contacting the cell with an effective amount of a compound, or a pharmaceutically acceptable salt thereof, having a structure of:
- wherein:
- A is a 6 membered aryl ring;
- C is a 6-membered aryl ring;
- each R1 is independently selected from hydrogen or optionally-substituted lower alkyl;
- a is 0, 1, or 2;
- R2 is selected from hydroxyl or halogen;
- R8 and R9 together with the linking nitrogen atom form a 4 to 7 membered optionally-substituted N-hetero- mono- or bi-cyclic ring with one or two hetero atoms independently selected from nitrogen and oxygen;
- each R3 is independently selected from halogen, lower haloalkyl, or optionally-substituted lower alkyl;
- b is 0 to 4;
- R4 is selected from halogen, lower haloalkyl, or optionally-substituted lower alkyl;
- each R5 is independently selected from halogen, lower haloalkyl, or optionally-substituted lower alkyl;
- d is 0, 1, or 2;
- R6 is selected from methyl, trifluoromethyl, or phenyl;
- Z is selected from nitrogen or oxygen;
- if Z is nitrogen, R7 is selected from hydrogen, hydroxyl, halogen, lower haloalkyl, or optionally-substituted lower alkyl, and if Z is oxygen, R7 is not present;
- and
- wherein each substituted lower alkyl and substituted N-hetero- mono- or bi-cyclic ring is independently selected from a lower alkyl or N-hetero- mono- or bi-cyclic ring wherein one or more hydrogen atoms are replaced with C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C3-8cycloalkyl, hydroxyl, oxo, C1-6alkoxy, aryloxy, C1-6alkoxyaryl, C1-6alkylhalo, C1-6alkoxyhalo, carboxyl, cyano, nitro, amino, acyl, amido, aminoacyl, mercapto, alkylthio, thioxo, sulfates, sulfonates, sulfinyl, sulfonyl, sulfonylamido, aryl, arC1-6alkyl, heterocyclyl, heteroaryl, or halogen.
Dependencies are inferred from the claim text.